Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Reset all filters
01 5Nanjing Well Pharmaceutical
02 2Actylis
03 15BASF
04 4Finar
05 1Ideal Cures
06 7Kerry
07 1Kima Chemical
08 1Lonza Capsugel
09 2Nomisma Healthcare
10 2The Dow Chemical Company
Reset all filters
01 6Capsule
02 3Cream / Lotion / Ointment
03 3Gel
04 1Injectable / Parenteral
05 1Softgel Capsule
06 1Softgels
07 1Solution
08 17Tablet
09 2Topical Film
10 4Transdermal Patch
11 1Transdermal patches
Reset all filters
01 6China
02 15Germany
03 7India
04 12U.S.A
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : NA
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand : POLYETHYLENE GLYCOL 400
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : NA
Grade : Parenteral, Topical, Oral
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactic Acid, Polyethylene Glycol Excipient
Dosage Form : Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly L Lactic Acid, Polyethylene Glycol Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : PLLA-PEG
Applications : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Grade : Oral, Parenteral
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade :
Application : Controlled & Modified Release, Direct Compression, Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs :
Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade :
Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Category : Controlled & Modified Release, Direct Compression, Granulation
Brand : KOLLIDON SR
Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)
Technical Specs : Not Available
Grade : Not Available
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient
Dosage Form : Tablet
Grade : Oral, Parenteral
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : PLGA-PEG
Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Grade : Oral, Parenteral
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release, Topical
Pharmacopoeia Ref :
Technical Specs :
Ingredient(s) : Polyethylene Glycol Excipient
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Tablet
Grade : Topical and Oral
Ingredient(s) : Polyethylene Glycol Excipient
Dosage Form : Capsule, Cream / Lotion / Ointment, Gel, Tablet
Category : Controlled & Modified Release, Topical
Brand : POLYETHYLENE GLYCOL 400
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Grade : Topical and Oral
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Brand : METHOCEL™
Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Grade : Not Available
Dosage Form : Tablet
Grade : Oral
Brand Name : Hydroxypropyl Methyl Cellul...
Application : Controlled & Modified Release
Excipient Details : Hydroxypropyl Methyl Cellulose (75K100) is used in the production of controlled-release tablets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Oral
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : HYDROXYPROPYL METHYL CELLULOSE (75K100)
Applications : Hydroxypropyl Methyl Cellulose (75K100) is used in the production of controlled-release tablets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Dosage Form : Tablet
Grade :
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Enteric Coatings
Pharmacopoeia Ref :
Technical Specs :
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade :
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Category : Coating Systems & Additives, Controlled & Modified Release
Brand : SHEFFCOAT™
Applications : Enteric Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Grade : Not Available
Dosage Form : Tablet
Grade :
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref :
Technical Specs :
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade :
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Category : Coating Systems & Additives, Controlled & Modified Release
Brand : SHEFFCOAT™ CG
Applications : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Grade : Not Available
Dosage Form : Tablet
Grade :
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Enteric Coatings
Pharmacopoeia Ref :
Technical Specs :
Ingredient(s) : Ethylcellulose, Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade :
Ingredient(s) : Ethylcellulose, Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Category : Coating Systems & Additives, Controlled & Modified Release
Brand : SHEFFCOAT™ EC
Applications : Enteric Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Grade : Not Available